Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...
The following is a summary of “Risks of adverse events with mirtazapine for adults with major depressive disorder: a ...
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.
Monty Minter, director of the Downing Counseling Clinic, shares strategies for finding light during the darker months ...
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
(HealthDay News) — Preventive psychological interventions may be effective for adults with subthreshold depressive symptoms, according to a review published online in the December issue of The Lancet ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII ...
People with bipolar I disorder have had at least one manic episode preceded or followed by hypomanic or major depressive ...
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...
The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...